Kate Law, Cancer Research UK's director of clinical research, added:
In general the outlook for leukaemia patients has improved dramatically in recent decades. But when leukaemia is diagnosed in older people its much harder to treat and there is a real need for effective treatments that are suitable for this age group.
Importantly this new trial shows that GO may have particular benefits for patients over 60, who may be unsuitable for other more intensive treatments. This is good news and we are now looking to see if these results can be replicated in younger patients.
More top news
Life-changing gene therapy for cystic fibrosis sufferers could be available in the next five years following a landmark trial.
A report warns UK has a 'mountain to climb' in reducing preventable hospital admissions and improving survival rates for common diseases.
After the thundery activity overnight, clears skies follow leading to a sunny, humid day. Then more thundery outbreaks to come.